• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT? PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT? PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911420300
Device Problem Occlusion Within Device (1423)
Patient Problems Angina (1710); Dyspnea (1816); Thrombosis (2100); Discomfort (2330)
Event Date 04/06/2015
Event Type  Injury  
Event Description
(b)(6) clinical study.It was reported that angina and stent thrombosis occurred.In (b)(6) 2013, the patient presented due to stable angina.Subsequently, coronary angiography and index procedure were performed.The target lesion #1 was a de novo lesion located in the proximal left circumflex (lcx) with 90% stenosis and was 15 mm long with a reference vessel diameter of 3.0 mm.The lesion was treated with direct stent placement using a 3.0 mm x 20 mm promus element¿ plus stent, resulting to 0% residual stenosis.The target lesion # 2 was a de novo lesion located in the left main coronary artery (lmca) with 70% stenosis and was 5 mm long with a reference vessel diameter of 3.0 mm.The lesion was treated with direct stent placement using a 3.0 mm x 8 mm promus element¿ plus stent, resulting to 0% residual stenosis.One day post procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2015, the patient presented emergently with complaints of chest discomfort associated with dyspnea and was hospitalized.The coronary angiography revealed 70% in-stent restenosis (isr) of previously deployed 3.0 mm x 20 mm promus element¿ plus stent in the lcx, which was reported as stent thrombosis by site.The 70-90% stenosis extending from proximal lcx to distal lcx was treated with direct stent placement using 2.75 mm x 12 mm, 3.00 mm x 12 mm and 3.0 mm x 23 mm non-bsc drug eluting stents.The event was considered as not resolved at the time of reporting.Two days post procedure, the patient was discharged on aspirin and clopidogrel.
 
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT? PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4743059
MDR Text Key5883676
Report Number2134265-2015-02671
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/10/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/01/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/10/2013
Device Model NumberH7493911420300
Device Catalogue Number39114-2030
Device Lot Number0015796615
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/10/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/22/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age67 YR
-
-